NCT07013565
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07013565 |
| Title | Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL (ACCELERATE) |
| Acronym | ACCELERATE |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | New York Medical College |
| Indications | |
| Therapies | |
| Age Groups: | adult | child |
| Covered Countries | USA |
CKB BOOST